Clinical Research Center of Reading — Wyomissing, Pennsylvania

Clinical Research Center of Reading is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical Research Center of Reading has participated in 12 clinical trials.

Therapeutic areas: Plaque Psoriasis, Rheumatoid Arthritis, Sjogren's Syndrome.

Sponsors: Coherus Oncology, Inc., Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Center of Reading?

Clinical Research Center of Reading has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Center of Reading conducted?

Clinical Research Center of Reading has 12 clinical trials on record. Their work covers Plaque Psoriasis, Rheumatoid Arthritis, Sjogren's Syndrome.

Is Clinical Research Center of Reading accredited by Crixeo Health?

Yes — Clinical Research Center of Reading holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Research Center of Reading?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.